|Articles|January 19, 2016
BioClinica Acquires Clinverse
The acquisition adds Clinverse’s automated financial management technology solutions to Bioclinica’s portfolio of solutions.
Advertisement
BioClinica clinical trials services and technology provider, announced that it has acquired Clinverse. The acquisition adds Clinverse’s automated financial management technology solutions to Bioclinica’s portfolio of solutions and services. Clinverse becomes a part of BioClinica’s eHealth Solutions business segment.
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
3
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
4
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
